Malaria vaccine could be licenced in 2011
The most clinically advanced malaria vaccine that is capable of reducing the incidence of malaria by more than 50 per cent in African infants and young children, may be licenced for use by 2011 if results of the final efficacy study commence early next year are anything to go by.
Researchers are targeting a possible new weapon in the fight against malaria, science that could also be applied in the fight against other devastating mosquito-borne illnesses, according to a Vanderbilt study published in PLOS ONE.